Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Federal Regulatory Actions Against Healthcare Consolidation

From the College  |  Issue: July 2024  |  June 8, 2024

Private equity firms have long been active in healthcare settings. Recently, however, acquisitions of physician practices have blasted into the stratosphere. Private equity investors spent more than $200 billion on healthcare acquisitions in 2021 alone and $1 trillion in the past decade.1 A recent study showed that in 13% of metropolitan areas, a single private equity firm owns more than half the market for certain specialties.2

The implications of this consolidation are concerning. Research has shown that mortality rates may slightly decrease, but adverse event rates increase in hospitals after they are acquired by private equity firms.3 The impact on the financial stability of patients and healthcare facilities and providers alike is more staggering. Patient costs increased by more than 30% in some cases, and nearly a quarter of all healthcare companies that declared bankruptcy in 2023 were owned by private equity firms.4,5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Federal regulators have finally begun to take note. Here is what rheumatologists need to know about what the federal government is doing to rein in healthcare consolidation and address its harmful impact on care quality. Note: Rheumatologists subjected to practices they feel are in violation of antitrust law can submit complaints at https://www.justice.gov/atr/HealthyCompetition.

Federal Actions

Earlier this year, the U.S. Department of Justice (DOJ), Federal Trade Commission (FTC) and Department of Health & Human Services (HHS) released a request for information seeking public comment on the intersection of antitrust law and certain types of private equity transactions in the healthcare sector. It also sought comment on the effects of consolidation in the healthcare sector, the types of transactions that most often lead to adverse healthcare outcomes, and what actions federal regulators should consider taking.

In recent months, the FTC and DOJ separately took action to rein in antitrust behavior. In April, the FTC banned noncompete agreements in the for-profit sector, which limit employment opportunities for many workers.6 In May, the DOJ formed the Antitrust Division’s Task Force on Health Care Monopolies and Collusion (HCMC).7 The aim of this task force is to steer the division’s approach to cracking down on actors who are acting against the public’s trust in the healthcare sector. As such, the HCMC will field anti-competition concerns from all stakeholders in the healthcare sector.

To assist the task force in this endeavor, ACR members can submit a complaint at https://www.justice.gov/atr/HealthyCompetition if they have been adversely impacted by healthcare consolidation. The site also provides links to the text of each federal antitrust law that applies to healthcare consolidation and lists relevant examples of behavior that violates these statutes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegePractice Support Tagged with:antitrustnoncompete agreementsRegulation

Related Articles

    Beware Antitrust Laws When Considering Healthcare Mergers

    March 1, 2015

    Analysis of laws governing collaboration of healthcare systems, hospitals and physician practices should be done before consolidating

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

    The 2023 ARP President’s Awards

    February 9, 2024

    SAN DIEGO—During ACR Convergence 2023 in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s Awards. The ARP president can choose to honor ACR/ARP members or teams performing outstanding…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences